Search clinical trials for: PMK-S005

Total 2366 results

PharmaKing

Completed

A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers

Gastritis | Gastric Ulcer

Korea, Republic of
PharmaKing

Completed

Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users

Peptic Ulcer

Korea, Republic of
Solvay Pharmaceuticals

Terminated

Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine

Healthy Subjects

Finland, Germany
HK inno.N Corporation

Unknown

A Study to Evaluate Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 in Healthy Male Subjects

Healthy

Korea, Republic of
Turning Point Therapeutics, Inc.

Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Lymphoma | Locally Advanced Solid Tumors | Metastatic Solid Tumors | Primary CNS Tumors

United States, Korea, Republic of, Spain, Singapore, Taiwan, Australia, Italy, Canada, France, Denmark, United Kingdom
S-Infinity Pharmaceuticals Co., Ltd

Not yet recruiting

A Phase I Study of XH-S004 in Healthy Volunteers

Healthy Adults

China
Turning Point Therapeutics, Inc.

Withdrawn

A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Repotrectinib in Advanced Cancer Patients

Metastatic Solid Tumor | Locally Advanced Solid Tumor

United States, Spain
HK inno.N Corporation

Completed

Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians

Healthy

Korea, Republic of
Longbio Pharma

Recruiting

A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants

Paroxysmal Nocturnal Hemoglobinuria (PNH)

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

High-risk Non-muscle Invasive Bladder Cancer

China
Pharmiva AB
CPS Research; Scandinavian Development Services AB; Key2Compliance AB

Active, not recruiting

Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis

Bacterial Vaginosis | Vaginal | Microbiology

Sweden, United Kingdom
Staidson Biopharma Inc.

Completed

The Safety and Tolerability of STSA-1005 Following Intravenous Infusion in Healthy Subjects

Healthy

United States
Novo Nordisk A/S

Completed

First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis

Inflammation | Healthy | Rheumatoid Arthritis

Germany
Seelos Therapeutics, Inc.

Withdrawn

SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease ([STRIVE-AD])

Alzheimer's Disease

Australia
S-Infinity Pharmaceuticals Co., Ltd

Not yet recruiting

A Phase I Study of XH-S003 in Healthy Volunteers

Healthy Adults

China
Veralox Therapeutics

Completed

Phase I Study of VLX-1005 in Healthy Subjects

Safety and Tolerability in Healthy Volunteers

United States
MedSIR
Medical University of Vienna

Not yet recruiting

REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis (REPOSE)

NSCLC | Brain Metastases | ROS1 Gene Rearrangement
Precigen, Inc

Recruiting

Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Stage III Fallopian Tube... and other conditions

United States
Eleven Biotherapeutics

Completed

Phase 1 Study for Safety and Tolerability of EBI-005 Topically Administered to Eyes of Healthy Adult Subjects (EBI-005-1)

Dry Eye

United States
Hunazine Biotech S.L.

Recruiting

Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera

Cholera

Bangladesh
Pharmiva AB
Key2Compliance; Replior AB

Completed

A User Study With Vernivia® for Bacterial Vaginosis. (USV01)

Bacterial Vaginoses

Sweden
BioLite, Inc.

Completed

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

Major Depressive Disorder

Taiwan, United States
S-Infinity Pharmaceuticals Co., Ltd

Recruiting

A Phase I Study of XH-S002 in Healthy Volunteers

Healthy Adults

China
S-Infinity Pharmaceuticals Co., Ltd

Recruiting

A Phase 1 Study of XH-S003 in Healthy Volunteers

Healthy

Australia
101 Therapeutics

Active, not recruiting

Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects

Virus Diseases | COVID-19 | Infectious Disease | Glucocorticoids Toxicity

India
AbbVie

Terminated

A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)

Breast Cancer

United States
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Recruiting

A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects

Healthy Subject

China
Region Skane
Folksam; Swedish Football Association; Swedish National Centre for Research in...

Completed

Preventing Knee Injuries in Adolescent Female Football Players

Knee Injury

Sweden
BJ Bioscience, Inc.

Active, not recruiting

A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma

Advanced Solid Tumor or Lymphoma

United States
Taipei Veterans General Hospital, Taiwan
Apollo Medical Optics, Ltd

Completed

Application of High Resolution Optical Coherence Tomography in Skin Disease: Amyloidosis and Differential Diagnosis

Amyloidosis

Taiwan
Mackay Memorial Hospital
Apollo Medical Optics, Ltd

Completed

Early Feasibility Study: Application of OCT Imaging in Dermatology

Skin Diseases

Taiwan
Seelos Therapeutics, Inc.

Terminated

STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia (STRIDES)

Spinocerebellar Ataxia Type 3

United States, Spain, Korea, Republic of, Australia, United Kingdom, Brazil, Germany, Portugal
University of Glasgow

Unknown

Evaluation of the New Orleans Intervention for Infant Mental Health (BEST?)

Maltreated Infants

United Kingdom
Xenon Pharmaceuticals Inc.

Completed

A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

Acne Vulgaris

Canada
Dushu Lake Hospital Affiliated to Soochow University

Recruiting

Natural Killer (NK) Cells (XS005) Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)

Glioblastoma | GBM

China
Sigilon Therapeutics, Inc.

Withdrawn

Safety and Efficacy of Encapsulated Allogeneic MPS-1 Therapy

MPS I | MPS1-S | MPS1-HS

Brazil, United Kingdom
Integrum
University Medical Center Groningen; Sahlgrenska University Hospital, Sweden; National University of Ireland, Galway, Ireland and other collaborators

Completed

Phantom Motor Execution Via MPR, VR/AR, and SG, as a Treatment of PLP

Phantom Limb Pain

United States, Canada, Ireland, Netherlands, Slovenia, Sweden, Germany
Eleven Biotherapeutics

Completed

A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis (EBI-005-AC-2)

Allergic Conjunctivitis (AC)

United States
Sound Pharmaceuticals, Incorporated
Medical University of South Carolina; Cystic Fibrosis Foundation

Enrolling by invitation

SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity

Ototoxicity

United States
101 Therapeutics

Terminated

A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care

COVID-19

Israel
Shanghai Junshi Bioscience Co., Ltd.
Sponsor GmbH

Recruiting

A Clinical Study of JS005 in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

China
Sadick Research Group

Completed

Poly-L-lactic Acid for Skin Quality

Skin Aging

United States
American Medical Systems

Completed

Evaluation of the 2005 AMS (American Medical System) IPP (Inflatable Penile Prosthesis)

Erectile Dysfunction

United States
GlaxoSmithKline

Completed

Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years

Influenza

Germany
GlobeImmune

Completed

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection

Hepatitis C

United States
Gynuity Health Projects
International Centre for Diarrhoeal Disease Research, Bangladesh

Completed

Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control Study

Preeclampsia

Bangladesh, Mexico
Shanghai Junshi Bioscience Co., Ltd.

Completed

Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing

Moderate to Severe Psoriasis

China
Gynuity Health Projects

Completed

Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Survey

Preeclampsia

Mexico
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health; University of Vermont

Completed

Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh

Dengue

Bangladesh
Chang Gung Memorial Hospital

Completed

Nonoperative Management Protocol in Patients With Blunt Splenic Injuries

Blunt Injuries

Search clinical trials for: PMK-S005

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations